Incepta Pharma launches insulin

Incepta Pharmaceuticals Ltd has introduced Maxsulin, a recombinant DNA (deoxyribonucleic acid) insulin and a life-saving drug to control blood glucose level of the diabetics, says a press release.
The insulin, which is a biotech product, was launched at a function yesterday in Dhaka where Managing Director of the company Abdul Muktadir, among others, was present.
Every batch of the insulin will be marketed after ensuring its quality as per the British Pharmacopoeia, the authoritative collection of standards for UK medicinal substances and the official source of all UK pharmaceutical quality standards, the release adds.